JP2014527396A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014527396A5 JP2014527396A5 JP2014509528A JP2014509528A JP2014527396A5 JP 2014527396 A5 JP2014527396 A5 JP 2014527396A5 JP 2014509528 A JP2014509528 A JP 2014509528A JP 2014509528 A JP2014509528 A JP 2014509528A JP 2014527396 A5 JP2014527396 A5 JP 2014527396A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- acid sequence
- sequence represented
- heavy chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161530194P | 2011-09-01 | 2011-09-01 | |
| US61/530,194 | 2011-09-01 | ||
| US201261659637P | 2012-06-14 | 2012-06-14 | |
| US61/659,637 | 2012-06-14 | ||
| PCT/JP2012/072667 WO2013032032A1 (en) | 2011-09-01 | 2012-08-30 | Anti-human xcr1 antibodies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014527396A JP2014527396A (ja) | 2014-10-16 |
| JP2014527396A5 true JP2014527396A5 (https=) | 2015-10-01 |
| JP5989096B2 JP5989096B2 (ja) | 2016-09-07 |
Family
ID=46881120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014509528A Expired - Fee Related JP5989096B2 (ja) | 2011-09-01 | 2012-08-30 | 抗ヒトｘｃｒ１抗体 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9371389B2 (https=) |
| EP (1) | EP2751140B1 (https=) |
| JP (1) | JP5989096B2 (https=) |
| KR (1) | KR101767717B1 (https=) |
| CN (1) | CN103764680B (https=) |
| AR (1) | AR087749A1 (https=) |
| AU (1) | AU2012302596B2 (https=) |
| BR (1) | BR112014004352A2 (https=) |
| CA (1) | CA2846370C (https=) |
| ES (1) | ES2684173T3 (https=) |
| HK (1) | HK1199038A1 (https=) |
| IL (1) | IL231075A (https=) |
| IN (1) | IN2014CN01466A (https=) |
| MX (1) | MX346560B (https=) |
| MY (1) | MY166152A (https=) |
| PH (1) | PH12014500384A1 (https=) |
| RU (1) | RU2619180C2 (https=) |
| TW (1) | TWI563004B (https=) |
| WO (1) | WO2013032032A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10071170B2 (en) | 2013-06-24 | 2018-09-11 | Ablbio | Antibody-drug conjugate having improved stability and use thereof |
| RS63482B1 (sr) * | 2015-08-05 | 2022-09-30 | Acticor Biotech | Nova anti-humana gpvi antitela i njihove upotrebe |
| TWI866194B (zh) | 2017-02-03 | 2024-12-11 | 法商艾提寇生物技術公司 | 使用抗人類ｇｐｖｉ抗體抑制血小板凝集 |
| WO2018146074A1 (en) | 2017-02-07 | 2018-08-16 | Vib Vzw | Immune-cell targeted bispecific chimeric proteins and uses thereof |
| CN107312092B (zh) * | 2017-05-04 | 2020-12-11 | 华南农业大学 | 一种斜带石斑鱼ccr12的多克隆抗体制备方法及其应用 |
| US20210130776A1 (en) * | 2017-09-29 | 2021-05-06 | The Broad Institute, Inc. | Methods and compositions for modulating suppression of lymphocyte activity |
| EP3743448A4 (en) * | 2018-01-26 | 2021-11-03 | Orionis Biosciences, Inc. | XCR1 BINDING AGENTS AND USES THEREOF |
| US12410225B2 (en) | 2018-11-08 | 2025-09-09 | Orionis Biosciences, Inc | Modulation of dendritic cell lineages |
| US20220073630A1 (en) | 2018-12-28 | 2022-03-10 | Hoffmann-La Roche, Inc. | A peptide-mhc-i-antibody fusion protein for therapeutic use in a patient with amplified immune response |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5786210A (en) | 1994-02-08 | 1998-07-28 | Schering Corporation | Mammalian thymokine genes |
| AU2001250412A1 (en) * | 2000-03-31 | 2001-10-08 | Ipf Pharmaceuticals Gmbh | Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| WO2002059608A2 (en) | 2000-11-29 | 2002-08-01 | Lifespan Biosciences, Inc. | Compositions and methods related to chemokine (c motif) xc receptor 1 (ccxcr1) |
| US20050136033A9 (en) | 2002-08-13 | 2005-06-23 | Matthias Mack | Method of treating allergen induced airway disease |
| WO2004072646A1 (en) * | 2003-02-13 | 2004-08-26 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 5 (gpr5) |
| EP1698902A1 (en) * | 2005-03-01 | 2006-09-06 | DKFZ Deutsches Krebsforschungszentrum | Use of XCR1 for diagnosing or monitoring of immune tolerance |
| CN101293924A (zh) | 2007-04-24 | 2008-10-29 | 上海国健生物技术研究院 | 骨桥蛋白的功能表位、与其特异性结合的单克隆抗体及其在制备抗肿瘤转移药物中的用途 |
| EP2062592A1 (en) * | 2007-11-20 | 2009-05-27 | BUNDESREPUBLIK DEUTSCHLAND letztvertreten durch das Robert Koch-Institut vertreten durch seinen Präsidenten | System for delivery into a XCR1 positive cell and uses thereof |
| KR20110128876A (ko) * | 2009-02-16 | 2011-11-30 | 바이오렉스 쎄라퓨틱스, 인코포레이티드 | 인간화된 항-ｃｄ20 항체 및 이용 방법 |
-
2012
- 2012-08-30 JP JP2014509528A patent/JP5989096B2/ja not_active Expired - Fee Related
- 2012-08-30 TW TW101131633A patent/TWI563004B/zh not_active IP Right Cessation
- 2012-08-30 AU AU2012302596A patent/AU2012302596B2/en not_active Ceased
- 2012-08-30 AR ARP120103217A patent/AR087749A1/es unknown
- 2012-08-30 MY MYPI2014700412A patent/MY166152A/en unknown
- 2012-08-30 ES ES12761822T patent/ES2684173T3/es active Active
- 2012-08-30 IN IN1466CHN2014 patent/IN2014CN01466A/en unknown
- 2012-08-30 CA CA2846370A patent/CA2846370C/en not_active Expired - Fee Related
- 2012-08-30 HK HK14112359.4A patent/HK1199038A1/xx unknown
- 2012-08-30 PH PH1/2014/500384A patent/PH12014500384A1/en unknown
- 2012-08-30 BR BR112014004352A patent/BR112014004352A2/pt not_active Application Discontinuation
- 2012-08-30 CN CN201280041366.2A patent/CN103764680B/zh not_active Expired - Fee Related
- 2012-08-30 WO PCT/JP2012/072667 patent/WO2013032032A1/en not_active Ceased
- 2012-08-30 MX MX2014002078A patent/MX346560B/es active IP Right Grant
- 2012-08-30 RU RU2014106832A patent/RU2619180C2/ru not_active IP Right Cessation
- 2012-08-30 US US14/240,090 patent/US9371389B2/en not_active Expired - Fee Related
- 2012-08-30 KR KR1020147004507A patent/KR101767717B1/ko not_active Expired - Fee Related
- 2012-08-30 EP EP12761822.1A patent/EP2751140B1/en not_active Not-in-force
-
2014
- 2014-02-20 IL IL231075A patent/IL231075A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014527396A5 (https=) | ||
| JP2014526898A5 (https=) | ||
| JP2015535828A5 (https=) | ||
| RU2571204C3 (ru) | Специфические связывающие агенты против в7-н1 | |
| JP2020023523A5 (https=) | ||
| JP2016185981A5 (https=) | ||
| ME03806B (me) | Antitela protiv cd73 i njihova upotreba | |
| JP2013538057A5 (https=) | ||
| JP2018502060A5 (https=) | ||
| HRP20201375T1 (hr) | ANTI-BCMA ANTITIJELA, BISPECIFIČNI ANTIGEN VEŽUĆE MOLEKULE KOJE SE VEŽU ZA BCMA i CD3, I NJIHOVE UPOTREBE | |
| JP2016196468A5 (https=) | ||
| JP2014039548A5 (https=) | ||
| HRP20251181T1 (hr) | Protutijela na protein gprc5d, bispecifične molekule koje vezuju antigen i koje vezuju gprc5d i cd3 te njihove primjene | |
| JP2017530722A5 (https=) | ||
| AU2016204274A1 (en) | Antibodies that bind to OX40 and their uses | |
| JP2011509245A5 (https=) | ||
| PH12014501783A1 (en) | Anti-lipoarabinomannan antibody and immunoassay for acid-fast bacillary infection using the antibody | |
| JP2016508496A5 (https=) | ||
| JP2012034692A5 (https=) | ||
| JP2016507523A5 (https=) | ||
| RU2017105915A (ru) | Антитела против pd-1 | |
| JP2017052784A5 (https=) | ||
| HRP20240719T1 (hr) | Kimerna i humanizirana monoklonska protutijela protiv ljudskog ctla4 i njihova upotreba | |
| HRP20180147T1 (hr) | Cea protutijela | |
| NZ602892A (en) | Antibodies that bind human cd27 and uses thereof |